Predictive Oncology to be Acquired by Renovaro – M&A
What You Should Know:
– Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced its upcoming acquisition by Renovaro, Inc. (NASDAQ: RENB) in a strategic move aimed at accelerating innovation and improving…
Continue Reading